Onyx, the Leading CMS Interoperability Platform, Acquires InteropX to Accelerate Electronic Prior Auth & Data Exchange

Acquisition strengthens Onyx’s ability to help health plans modernize ePA, scale to meet CMS deadlines, and maximize ...
FiercePharma

Charitable Donations to be Made on Behalf of Visitors Who Pledge Their Commitment at the Experience

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced the launch of the Make Your Mark at the Multiple Myeloma Experience at the 54 th ...
Nasdaq

Onyx Enterprises Int’l, Corp. and Legacy Acquisition Corp. to Participate in SPACInsider-ICR Webinar on October 22nd at 2pm ET

With CARiD, Onyx has developed a distinctive proprietary technology platform for digital commerce and fulfillment, relying on insights extracted from nearly 14 billion data points, a physical ...
FiercePharma

Onyx Pharmaceuticals Appoints Dr. Pablo Cagnoni as Executive Vice President, Global Research & Development and Technical Operations

SOUTH SAN FRANCISCO, CA--(Marketwire - February 15, 2013) - Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced the appointment of Pablo J. Cagnoni, M.D., as Executive Vice President, Global ...
Yahoo Noticias en Español

Onyx Pharmaceuticals Completes Enrollment in FOCUS Phase 3 Carfilzomib Trial in Patients With Relapsed and Refractory Multiple Myeloma

SOUTH SAN FRANCISCO, CA--(Marketwire - Oct 15, 2012) - Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced that the company completed enrollment in the FOCUS trial, an international Phase 3 ...